A retrospective study of Human Immunodeficiency Virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South Africa

Table 1 Characteristics of pregnant HIV-infected women, 1 May 2008 to 31 May 2009, McCord Hospital

Maternal characteristics	N*	n	%	95% Confidence Intervals
Race	125
Black (South African)		119	95.2	89.8 - 98.2
Asian		4	3.2	0.9 - 8.0
White		1	0.8	0.0 - 4.4
Black (other African)		1	0.8	0.0 - 4.4
Parity	247
Primiparity		86	34.8	28.9 - 41.1
Multiparity		161	65.2	58.9 - 71.1
Maternal CD4 ⁺ count (cells/mm ³ )	250
< 200		68	27.2	21.8 - 33.2
200 – 499		147	58.8	52.4 - 65.0
≥ 500		35	14	9.9 - 18.9
Maternal antiretroviral regimen	258
ART for life		128	49.6	43.4 - 55.9
PMTCT:
Zidovudine, lamivudine. efavirenz from 28 weeks		85	32.9	27.2 - 39.0
Zidovudine from 28 weeks		40	15.5	11.3 - 20.5
sd-nevirapine + zidovudine and lamivudine for 7 days		4	1.6	0.4 - 3.9
Nevirapine only		1	0.4	0.0 - 2.1
Booking gestational age, weeks	246
0-12		29	11.8	8.0 - 16.5
13-27		155	63.0	56.6 - 69.1
≥ 28		62	25.2	19.9 - 31.1
Any illness during pregnancy	247
Yes		127	51.4	45.0 – 57.8
No		120	48.6	42.2 – 55.0
Pulmonary tuberculosis	127	12	9.4	5.0 -15.9
Mode of delivery	254
Emergency C/S		74	29.1	23.6 - 35.1
Booked C/S		89	35.0	29.2 - 41.3
NVD		91	35.8	29.9 - 42.1
Maternal mortality	256
No		255	99.6	97.8 – 100
Yes		1	0.4	0.0 - 2.2

N* The number of mothers across categories of maternal characteristics may not add up to 258 due to missing data.

ISSN: 1471-2431